How long does Montelukast (Singular) take to start working?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How Long Does Montelukast (Singulair) Take to Start Working?

Montelukast typically begins working within 1-2 hours after administration, with clinical benefits evident by day 2 of treatment (after 2 doses), though maximum effectiveness may take 2-4 weeks to achieve for some conditions. 1, 2

Onset of Action by Condition

Allergic Rhinitis

  • Significant improvement in daytime eye symptoms can be observed as early as day 1 (after first dose) 2
  • Significant improvements in daytime nasal symptoms, nighttime symptoms, and composite symptom scores occur by day 2 of treatment 2
  • By day 2, montelukast achieves over 70% of the overall treatment benefits seen at 2 weeks 2
  • Full therapeutic effect for seasonal allergic rhinitis is typically achieved within 1-4 weeks of daily treatment 3

Asthma

  • Improvements in lung function and reductions in as-needed β2-agonist usage are generally observed within 1 day after initiating therapy in children 2-14 years of age with persistent asthma 4
  • For exercise-induced bronchoconstriction (EIB), montelukast acts within 1-2 hours of oral administration and has a bronchoprotective effect lasting 24 hours 1
  • Maximum protection against EIB might not be retained in some individuals toward the end of the 24-hour period 1
  • For optimal prophylactic effect against EIB, montelukast should be taken at least 2 hours before exercise 1

Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

  • Symptom improvement begins within the first few weeks of treatment 1
  • In one study, total symptom scores improved from 5.9 to 1.75 over a 6-week treatment period 1
  • Significant reduction in most domains of health-related quality of life was observed after 4 weeks of treatment 1

Pharmacokinetic Considerations

  • Montelukast is rapidly absorbed following oral administration 5
  • Peak plasma concentration (Cmax) is achieved in 3-4 hours for the 10-mg film-coated tablet 5
  • For the 5-mg chewable tablet, peak concentration is achieved in 2-2.5 hours 5
  • For the 4-mg chewable tablet used in young children, peak concentration is achieved in 2 hours 5

Factors Affecting Response Time

  • Individual patient characteristics may influence response time 1
  • Concomitant medications may affect the onset of action 1
  • The specific condition being treated affects the timeline for symptom improvement 1
  • Food intake may delay the time to peak concentration but does not significantly affect overall bioavailability 5

Clinical Recommendations

  • For asthma control, montelukast should be taken daily as prescribed, with benefits typically beginning within the first day but optimal control may take several weeks 1, 4
  • For exercise-induced bronchoconstriction, take montelukast at least 2 hours before exercise for maximum protection 1
  • For allergic rhinitis, expect noticeable improvement within 1-2 days, with continued improvement over 2-4 weeks 2, 3
  • Unlike some medications that develop tolerance with continued use, montelukast maintains its effectiveness without developing tolerance during long-term treatment 1

Common Pitfalls and Caveats

  • Montelukast is not effective for acute bronchospasm or asthma attacks and should not be used for this purpose 1
  • Patients should not discontinue treatment prematurely if full benefits are not immediately apparent, as some therapeutic effects may take several weeks to fully develop 1, 4
  • If clear benefits are not observed within 4-6 weeks, alternative therapies or diagnoses should be considered 1
  • Montelukast should be used as part of a comprehensive asthma management plan, not as monotherapy for persistent asthma 1
  • When used for allergic rhinitis, the treatment effect of montelukast tends to be more persistent over time compared to some antihistamines 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.